Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer

Barbara A. Jereczek-Fossa; Laura Fariselli; Giancarlo Beltramo; Gianpiero Catalano; Flavia Serafini; Cristina Garibaldi; Raffaella Cambria; Lorenzo Brait; Marco Possanzini; Livia C. Bianchi; Andrea Vavassori; Dario Zerini; Franco Orsi; Ottavio de Cobelli; Roberto Orecchia

doi:10.1016/j.radonc.2009.04.001

Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer

Barbara A. Jereczek-Fossa, Laura Fariselli, Giancarlo Beltramo, Gianpiero Catalano, Flavia Serafini, Cristina Garibaldi, Raffaella Cambria, Lorenzo Brait, Marco Possanzini, Livia C. Bianchi, Andrea Vavassori, Dario Zerini, Franco Orsi, Ottavio de Cobelli, Roberto Orecchia

Research output: Contribution to journal › Article › peer-review

Abstract

We report on 14 patients treated with linac- or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrence from prostate cancer, up to the mean dose of 30 Gy/3 fractions. At the mean follow-up of 18.6 months, five patients experienced clinical out-field progression. Toxicity was minimal. Further investigation is warranted in order to identify the patients that benefit most from this treatment modality and to define the optimal association of such local approach with androgen deprivation. Hopefully, effective local therapy might reduce the burden of systemic therapies given to the recurrent/metastatic prostate cancer patients.

Original language	English
Pages (from-to)	14-17
Number of pages	4
Journal	Radiotherapy and Oncology
Volume	93
Issue number	1
DOIs	https://doi.org/10.1016/j.radonc.2009.04.001
Publication status	Published - Oct 2009

Keywords

Lymph node recurrence
Recurrent prostate cancer
Robotic stereotactic radiotherapy
Stereotactic radiotherapy

ASJC Scopus subject areas

Oncology
Radiology Nuclear Medicine and imaging
Hematology

Access to Document

10.1016/j.radonc.2009.04.001

Cite this

Jereczek-Fossa, B. A., Fariselli, L., Beltramo, G., Catalano, G., Serafini, F., Garibaldi, C., Cambria, R., Brait, L., Possanzini, M., Bianchi, L. C., Vavassori, A., Zerini, D., Orsi, F., de Cobelli, O., & Orecchia, R. (2009). Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer. Radiotherapy and Oncology, 93(1), 14-17. https://doi.org/10.1016/j.radonc.2009.04.001

Jereczek-Fossa, BA , Fariselli, L, Beltramo, G, Catalano, G, Serafini, F, Garibaldi, C , Cambria, R, Brait, L, Possanzini, M, Bianchi, LC, Vavassori, A , Zerini, D , Orsi, F , de Cobelli, O & Orecchia, R 2009, 'Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer', Radiotherapy and Oncology, vol. 93, no. 1, pp. 14-17. https://doi.org/10.1016/j.radonc.2009.04.001

@article{f9445462fdd44a4f96e49cebf434728a,

title = "Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer",

abstract = "We report on 14 patients treated with linac- or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrence from prostate cancer, up to the mean dose of 30 Gy/3 fractions. At the mean follow-up of 18.6 months, five patients experienced clinical out-field progression. Toxicity was minimal. Further investigation is warranted in order to identify the patients that benefit most from this treatment modality and to define the optimal association of such local approach with androgen deprivation. Hopefully, effective local therapy might reduce the burden of systemic therapies given to the recurrent/metastatic prostate cancer patients.",

keywords = "Lymph node recurrence, Recurrent prostate cancer, Robotic stereotactic radiotherapy, Stereotactic radiotherapy",

author = "Jereczek-Fossa, {Barbara A.} and Laura Fariselli and Giancarlo Beltramo and Gianpiero Catalano and Flavia Serafini and Cristina Garibaldi and Raffaella Cambria and Lorenzo Brait and Marco Possanzini and Bianchi, {Livia C.} and Andrea Vavassori and Dario Zerini and Franco Orsi and {de Cobelli}, Ottavio and Roberto Orecchia",

year = "2009",

month = oct,

doi = "10.1016/j.radonc.2009.04.001",

language = "English",

volume = "93",

pages = "14--17",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

TY - JOUR

T1 - Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer

AU - Jereczek-Fossa, Barbara A.

AU - Fariselli, Laura

AU - Beltramo, Giancarlo

AU - Catalano, Gianpiero

AU - Serafini, Flavia

AU - Garibaldi, Cristina

AU - Cambria, Raffaella

AU - Brait, Lorenzo

AU - Possanzini, Marco

AU - Bianchi, Livia C.

AU - Vavassori, Andrea

AU - Zerini, Dario

AU - Orsi, Franco

AU - de Cobelli, Ottavio

AU - Orecchia, Roberto

PY - 2009/10

Y1 - 2009/10

N2 - We report on 14 patients treated with linac- or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrence from prostate cancer, up to the mean dose of 30 Gy/3 fractions. At the mean follow-up of 18.6 months, five patients experienced clinical out-field progression. Toxicity was minimal. Further investigation is warranted in order to identify the patients that benefit most from this treatment modality and to define the optimal association of such local approach with androgen deprivation. Hopefully, effective local therapy might reduce the burden of systemic therapies given to the recurrent/metastatic prostate cancer patients.

AB - We report on 14 patients treated with linac- or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrence from prostate cancer, up to the mean dose of 30 Gy/3 fractions. At the mean follow-up of 18.6 months, five patients experienced clinical out-field progression. Toxicity was minimal. Further investigation is warranted in order to identify the patients that benefit most from this treatment modality and to define the optimal association of such local approach with androgen deprivation. Hopefully, effective local therapy might reduce the burden of systemic therapies given to the recurrent/metastatic prostate cancer patients.

KW - Lymph node recurrence

KW - Recurrent prostate cancer

KW - Robotic stereotactic radiotherapy

KW - Stereotactic radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=70349324507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349324507&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2009.04.001

DO - 10.1016/j.radonc.2009.04.001

M3 - Article

C2 - 19409636

AN - SCOPUS:70349324507

SN - 0167-8140

VL - 93

SP - 14

EP - 17

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

IS - 1

ER -

Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this